ELOVL4-Mediated Production of Very Long-Chain Ceramides Stabilizes Tight Junctions and Prevents Diabetes-Induced Retinal Vascular Permeability.
Nermin M Kady, Xuwen Liu, Todd A Lydic...
https://pubmed.ncbi.nlm.nih.gov/29362226/Actively Recruiting
Led by Hywel Dda Health Board · Updated on 2025-04-10
120
Participants Needed
1
Research Sites
N/A
Total Duration
Diabetic Retinopathy DR is a common complication of diabetes that damages the small blood vessels in the retina, potentially leading to vision loss. Researchers are studying the metabolic and lipid profiles in people with type 2 diabetes at different stages of DR to better understand the diseases underlying mechanisms. This observational study aims to identify chemicals in the blood and the role of gut bacteria that may influence retinal damage and diabetic eye disease progression. Participants will provide blood and urine samples for detailed lipidomic and metabolomic analyses, while researchers will review medical records, previous eye photographs, and specialized retinal scans to classify the severity of DR. The study groups include patients at various stages of diabetic eye disease, ranging from no retinopathy to proliferative DR and diabetic macular edema DMO without prior treatment. Sample collection is coordinated with routine clinic visits to minimize participant burden. During the study, participants data and biological samples will be securely collected and anonymized. Researchers will analyze blood plasma and urine metabolites over several years to explore potential biomarkers and mechanisms related to DR severity. The primary outcome is the analysis of serum lipid profiles associated with DR, supported by secondary analyses of metabolic pathways and microbiome interactions. The study is planned to start recruiting in early 2025, with ongoing sample analysis continuing until 2030.
CONDITIONS
Investigating the Metabolic and Lipidomic Profiles That Are Associated With Varying Grades of Diabetic Maculopathy and Retinopathy in South Wales
F
Francis WB Sanders, MB BChir PhD FRCOphth
E
Eirini Skiadaresi
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Hywel Dda Health Board
Lead Sponsor
University of Aberdeen
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 12 months
Participants who undergo routine diabetes care and ophthalmic assessments provide blood and urine samples for lipidomic and metabolomic analysis to investigate changes associated with diabetic retinopathy.
Sample collection during routine clinic visits
Duration - Up to 5 years from sample collection
Participants’ blood plasma and urine metabolites and lipids are analyzed over several years to identify potential biomarkers and understand metabolic pathways related to diabetic retinopathy.
No additional visits; analysis performed on collected samples
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
6
Have more questions? Get in touch with our team for quick support
Nermin M Kady, Xuwen Liu, Todd A Lydic...
https://pubmed.ncbi.nlm.nih.gov/29362226/Yan Levitsky, Sandra S Hammer, Kiera P Fisher...
https://pubmed.ncbi.nlm.nih.gov/32481596/Irl B Hirsch, Michael Brownlee
https://pubmed.ncbi.nlm.nih.gov/20530784/Jiaxian Li, Ziyang Huang, Yu Jin...
https://pubmed.ncbi.nlm.nih.gov/37691227/Marc Labetoulle, Christophe Baudouin, Jose M Benitez Del Castillo...
https://pubmed.ncbi.nlm.nih.gov/38460758/Zhen Ling Teo, Yih-Chung Tham, Marco Yu...
https://pubmed.ncbi.nlm.nih.gov/33940045/Zixi Zhou, Zheng Zheng, Xiaojing Xiong...
https://pubmed.ncbi.nlm.nih.gov/34722512/Rui Wang, Qiu-Yuan Wang, Yang Bai...
https://pubmed.ncbi.nlm.nih.gov/37744925/Susu Feng, Lin Guo, Sijing Wang...
https://pubmed.ncbi.nlm.nih.gov/37465650/Hywel Dda Health Board
Lead Sponsor
University of Aberdeen
Collaborating Sponsor